New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) — BioPlus Acquisition Corp. (“BIOS” or the “Company”) (Nasdaq: BIOS) announced today that (i) BIOS, Avertix Medical, Inc. and certain other parties have mutually agreed to terminate their previously announced business combination agreement and plan of reorganization (the “Business Combination Agreement”), effective…Read More
BioPlus Acquisition Corp Announces Termination of Business Combination Agreement with Avertix
